KP
Kathleen P. Gallagher
President, CEO & DirectorMs. Kathleen P. Gallagher, also known as Kath, is President, CEO & Director of Atrium Therapeutics, Inc. since December 2025. Ms. Kathleen P. Gallagher was Chief Program Officer at Avidity Biosciences, Inc. since October 2024 until February 27, 2026. She was Senior Vice President of Global Program and Head DM1 at Avidity Biosciences, Inc. since 2023 until October 2024 and also its Senior Vice President of Corporate Communications & Investor Relations until 2023. She joined Avidity Biosciences, Inc. in April 2021. She served as Vice President of Corporate Communications and Investor Relations at Akcea Therapeutics, Inc. until March 2020. Ms. Gallagher earned her B.S. degree in English from Boston University.
Positions
- Company NameAtrium Therapeutics, Inc.Stock CodeRNAPositionPresident, CEO & DirectorColleagues
- SBSarah BoyceIndependent Chair of the Board of Director
- BWBrendan WinslowChief Financial Officer
- HYHusam YounisChief Scientific Officer
- SKStephanie KenneyChief Corporate Affairs Officer
- SGSteven George HughesChief Medical Officer
- CBCarsten BoessIndependent Director
- TETroy Edward WilsonIndependent Director
- WMW. Michael F. FlanaganIndependent Director
